74 phenotypes from 2 alleles in 2 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Mpv17/Mpv17 CFW-Mpv17/J	abnormal auditory brainstem response	J:48661
	abnormal blood homeostasis	J:10661
	abnormal coat/hair pigmentation	J:143355
	abnormal cochlea morphology	J:48653
	abnormal glomerular capillary morphology	J:10661
	abnormal hepatocyte morphology	J:143355
	abnormal hypodermis muscle layer morphology	J:143355
	abnormal liver lobule morphology	J:143355
	abnormal liver sinusoid morphology	J:143355
	abnormal mitochondrial crista morphology	J:143355
	abnormal portal triad morphology	J:143355
	abnormal renal glomerulus morphology	J:108252, J:143355
	abnormal renal tubule morphology	J:108252
	abnormal renal/urinary system physiology	J:59102
	abnormal scala media morphology	J:48653
	abnormal sebaceous gland morphology	J:143355
	abnormal skin morphology	J:143355
	albuminuria	J:62419, J:108252
	anemia	J:10661
	cachexia	J:10661
	normal cellular phenotype	J:143355
	cochlear ganglion degeneration	J:48662
	cochlear ganglion hypoplasia	J:48653
	cochlear outer hair cell degeneration	J:48662
	cortical renal glomerulopathies	J:10661, J:108252
	decreased body weight	J:143355
	decreased circulating serum albumin level	J:10661, J:62419
	decreased erythrocyte cell number	J:10661
	decreased hair follicle number	J:143355
	decreased hemoglobin content	J:10661
	decreased hepatocyte mitochondrial DNA content	J:143355
	decreased locomotor activity	J:10661
	decreased mitochondrial DNA content	J:143355
	decreased muscle fiber mitochondrial DNA content	J:143355
	decreased subcutaneous adipose tissue amount	J:143355
	decreased urine osmolality	J:59102
	dilated mitochondrion	J:143355
	dilated renal tubule	J:10661
	expanded mesangial matrix	J:108252
	fused podocyte foot processes	J:10661
	glomerulosclerosis	J:10661, J:143355
	normal homeostasis/metabolism phenotype	J:143355
	hypertension	J:59102
	increased blood urea nitrogen level	J:10661
	increased circulating alanine transaminase level	J:143355
	increased circulating aspartate transaminase level	J:143355
	increased circulating cholesterol level	J:10661
	increased circulating creatine kinase level	J:143355
	increased circulating creatinine level	J:10661
	increased circulating lactate level	J:143355
	increased heart rate	J:59102
	increased kidney weight	J:62419
	increased or absent threshold for auditory brainstem response	J:48661
	increased urine protein level	J:10661, J:108252, J:143355
	increased urine sodium level	J:59102
	kidney degeneration	J:143355
	kidney failure	J:48662
	normal liver/biliary system phenotype	J:143355
	organ of Corti degeneration	J:48653, J:48662
	podocyte foot process effacement	J:108252
	polyuria	J:59102
	premature death	J:10661, J:27358, J:62419, J:143355
	renal glomerulus hypertrophy	J:10661, J:108252
	renal interstitial fibrosis	J:143355
sensorineural hearing loss	J:48661, J:48662
small sebaceous gland	J:143355
spiral ligament degeneration	J:48653, J:48662
stria vascularis degeneration	J:48653, J:48662
thin epidermis	J:143355
thin skin	J:143355
Mpv17em1(IMPC)J/Mpv17em1(IMPC)J C57BL/6NJ-Mpv17em1(IMPC)J/J	decreased circulating glucose level	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	increased blood urea nitrogen level	J:211773
	increased heart weight	J:211773
	thrombocytopenia	J:211773